Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Laryngectomy | 33 | 2023 | 243 | 8.370 |
Why?
|
Surgical Flaps | 47 | 2021 | 1671 | 6.070 |
Why?
|
Head and Neck Neoplasms | 64 | 2024 | 2895 | 6.070 |
Why?
|
Larynx, Artificial | 14 | 2018 | 69 | 5.120 |
Why?
|
Parotid Neoplasms | 12 | 2019 | 157 | 4.720 |
Why?
|
Free Tissue Flaps | 17 | 2024 | 331 | 4.360 |
Why?
|
Laryngeal Neoplasms | 19 | 2020 | 514 | 3.970 |
Why?
|
Carcinoma, Squamous Cell | 47 | 2024 | 4026 | 3.300 |
Why?
|
Esophagus | 13 | 2020 | 1033 | 2.980 |
Why?
|
Parotid Gland | 9 | 2023 | 175 | 2.890 |
Why?
|
Trachea | 12 | 2020 | 1089 | 2.650 |
Why?
|
Neck Dissection | 8 | 2021 | 201 | 2.310 |
Why?
|
Punctures | 12 | 2018 | 366 | 2.190 |
Why?
|
Prosthesis Implantation | 7 | 2018 | 592 | 2.100 |
Why?
|
Tongue Neoplasms | 10 | 2024 | 183 | 1.670 |
Why?
|
Oropharyngeal Neoplasms | 12 | 2022 | 491 | 1.620 |
Why?
|
Pharyngectomy | 9 | 2017 | 44 | 1.600 |
Why?
|
Carcinoma, Adenoid Cystic | 7 | 2022 | 262 | 1.540 |
Why?
|
Carcinoma, Mucoepidermoid | 3 | 2019 | 89 | 1.430 |
Why?
|
Neck | 8 | 2023 | 734 | 1.320 |
Why?
|
Paraganglioma | 3 | 2020 | 142 | 1.310 |
Why?
|
Salivary Gland Neoplasms | 9 | 2022 | 304 | 1.300 |
Why?
|
Hypopharyngeal Neoplasms | 2 | 2024 | 51 | 1.290 |
Why?
|
Postoperative Complications | 34 | 2024 | 15631 | 1.290 |
Why?
|
Mouth Neoplasms | 8 | 2023 | 596 | 1.250 |
Why?
|
Glossectomy | 6 | 2023 | 60 | 1.230 |
Why?
|
Pharyngeal Neoplasms | 5 | 2014 | 113 | 1.180 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2021 | 324 | 1.070 |
Why?
|
Facial Nerve | 4 | 2018 | 277 | 1.070 |
Why?
|
Pharyngeal Diseases | 5 | 2019 | 134 | 1.050 |
Why?
|
Prosthesis Failure | 5 | 2020 | 1204 | 1.030 |
Why?
|
Voice Quality | 7 | 2018 | 226 | 1.020 |
Why?
|
Paranasal Sinus Neoplasms | 7 | 2021 | 242 | 0.910 |
Why?
|
Facial Nerve Injuries | 2 | 2017 | 64 | 0.910 |
Why?
|
Esophagoscopy | 4 | 2020 | 396 | 0.900 |
Why?
|
Device Removal | 3 | 2020 | 630 | 0.890 |
Why?
|
Carotid Body Tumor | 2 | 2020 | 34 | 0.880 |
Why?
|
Voice | 2 | 2017 | 268 | 0.870 |
Why?
|
Oral Surgical Procedures | 3 | 2021 | 166 | 0.850 |
Why?
|
Neoplasm Staging | 22 | 2023 | 11121 | 0.850 |
Why?
|
Carcinoma, Acinar Cell | 2 | 2018 | 62 | 0.840 |
Why?
|
Cutaneous Fistula | 5 | 2016 | 79 | 0.820 |
Why?
|
Microsurgery | 6 | 2018 | 795 | 0.820 |
Why?
|
Salvage Therapy | 5 | 2024 | 1264 | 0.790 |
Why?
|
Thyroiditis, Subacute | 1 | 2021 | 11 | 0.780 |
Why?
|
Mandible | 6 | 2015 | 753 | 0.770 |
Why?
|
Deglutition Disorders | 4 | 2023 | 625 | 0.770 |
Why?
|
Facial Paralysis | 3 | 2011 | 346 | 0.760 |
Why?
|
Indians, North American | 3 | 2014 | 352 | 0.760 |
Why?
|
Adenoma, Pleomorphic | 2 | 2012 | 75 | 0.730 |
Why?
|
Retrospective Studies | 65 | 2024 | 80636 | 0.710 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2020 | 592 | 0.700 |
Why?
|
Blood Transfusion | 2 | 2018 | 1298 | 0.690 |
Why?
|
Speech, Esophageal | 4 | 2018 | 11 | 0.690 |
Why?
|
Humans | 206 | 2024 | 761504 | 0.680 |
Why?
|
Male | 138 | 2024 | 360804 | 0.680 |
Why?
|
Temporal Bone | 5 | 2011 | 683 | 0.680 |
Why?
|
Chylothorax | 2 | 2011 | 83 | 0.670 |
Why?
|
Tissue and Organ Harvesting | 3 | 2019 | 373 | 0.660 |
Why?
|
Dissection | 4 | 2019 | 298 | 0.660 |
Why?
|
Voice Disorders | 3 | 2018 | 286 | 0.650 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2011 | 118 | 0.650 |
Why?
|
Surgical Stomas | 2 | 2020 | 42 | 0.640 |
Why?
|
Middle Aged | 94 | 2024 | 220895 | 0.640 |
Why?
|
Sublingual Gland | 1 | 2018 | 11 | 0.630 |
Why?
|
Ranula | 1 | 2018 | 10 | 0.620 |
Why?
|
Papillomavirus Infections | 6 | 2022 | 1613 | 0.620 |
Why?
|
Laryngeal Diseases | 2 | 2020 | 243 | 0.620 |
Why?
|
Parathyroidectomy | 2 | 2011 | 242 | 0.610 |
Why?
|
Masks | 1 | 2020 | 208 | 0.600 |
Why?
|
Treatment Outcome | 45 | 2023 | 64680 | 0.600 |
Why?
|
Cranial Nerve Neoplasms | 2 | 2010 | 134 | 0.590 |
Why?
|
Otolaryngology | 6 | 2020 | 693 | 0.570 |
Why?
|
Tonsillar Neoplasms | 2 | 2016 | 50 | 0.570 |
Why?
|
Aged | 76 | 2021 | 169289 | 0.560 |
Why?
|
Palatal Neoplasms | 1 | 2017 | 37 | 0.560 |
Why?
|
Nasopharyngeal Neoplasms | 4 | 2016 | 290 | 0.560 |
Why?
|
Surgical Wound Infection | 6 | 2021 | 1527 | 0.550 |
Why?
|
Fascia | 2 | 2016 | 140 | 0.550 |
Why?
|
Speech, Alaryngeal | 2 | 2015 | 32 | 0.550 |
Why?
|
Carcinoma | 6 | 2021 | 2330 | 0.550 |
Why?
|
Hair Removal | 1 | 2017 | 40 | 0.540 |
Why?
|
Cysts | 4 | 2011 | 681 | 0.540 |
Why?
|
Intubation, Gastrointestinal | 2 | 2014 | 166 | 0.530 |
Why?
|
Forearm | 6 | 2023 | 427 | 0.530 |
Why?
|
Lymphatic Metastasis | 7 | 2022 | 2915 | 0.530 |
Why?
|
Myiasis | 1 | 2015 | 14 | 0.510 |
Why?
|
Catheters, Indwelling | 1 | 2018 | 426 | 0.510 |
Why?
|
Laryngoscopy | 2 | 2020 | 706 | 0.500 |
Why?
|
Pneumocephalus | 2 | 2008 | 47 | 0.500 |
Why?
|
Cervicoplasty | 1 | 2015 | 8 | 0.500 |
Why?
|
Mandibular Neoplasms | 3 | 2002 | 130 | 0.500 |
Why?
|
Female | 104 | 2024 | 392644 | 0.490 |
Why?
|
Pectoralis Muscles | 3 | 2020 | 85 | 0.490 |
Why?
|
Thrombosis | 5 | 2008 | 2942 | 0.490 |
Why?
|
Pneumonia, Aspiration | 1 | 2015 | 146 | 0.480 |
Why?
|
Suture Techniques | 2 | 2012 | 769 | 0.480 |
Why?
|
SEER Program | 4 | 2020 | 1450 | 0.480 |
Why?
|
Radiotherapy, Adjuvant | 8 | 2020 | 1784 | 0.470 |
Why?
|
Ear Auricle | 1 | 2014 | 31 | 0.470 |
Why?
|
Venous Thrombosis | 3 | 2016 | 1303 | 0.470 |
Why?
|
Anastomosis, Surgical | 8 | 2020 | 983 | 0.470 |
Why?
|
Neoplasm Recurrence, Local | 12 | 2024 | 9280 | 0.470 |
Why?
|
Bronchoscopy | 1 | 2020 | 909 | 0.460 |
Why?
|
Zygoma | 2 | 2011 | 52 | 0.450 |
Why?
|
Ulcer | 1 | 2015 | 204 | 0.450 |
Why?
|
Postoperative Hemorrhage | 2 | 2015 | 415 | 0.450 |
Why?
|
Social Work | 1 | 2015 | 159 | 0.440 |
Why?
|
Prostheses and Implants | 1 | 2020 | 1271 | 0.440 |
Why?
|
Antibiotic Prophylaxis | 3 | 2016 | 636 | 0.440 |
Why?
|
Enteral Nutrition | 3 | 2014 | 794 | 0.440 |
Why?
|
Prosthesis Design | 3 | 2015 | 2115 | 0.440 |
Why?
|
Tracheotomy | 2 | 2018 | 167 | 0.430 |
Why?
|
Graft Survival | 10 | 2015 | 3819 | 0.430 |
Why?
|
Respiratory Therapy | 1 | 2014 | 125 | 0.430 |
Why?
|
Electrosurgery | 2 | 2010 | 51 | 0.430 |
Why?
|
Hair | 1 | 2017 | 498 | 0.430 |
Why?
|
Facial Nerve Diseases | 3 | 2010 | 49 | 0.430 |
Why?
|
Esophageal Spasm, Diffuse | 2 | 2004 | 3 | 0.420 |
Why?
|
Biopsy, Needle | 5 | 2018 | 1626 | 0.420 |
Why?
|
Burnout, Professional | 1 | 2021 | 704 | 0.420 |
Why?
|
Hyperbaric Oxygenation | 2 | 2020 | 165 | 0.410 |
Why?
|
Head | 4 | 2023 | 924 | 0.410 |
Why?
|
Pharynx | 4 | 2008 | 432 | 0.400 |
Why?
|
Pacemaker, Artificial | 1 | 2018 | 807 | 0.400 |
Why?
|
Hospital Costs | 1 | 2018 | 947 | 0.400 |
Why?
|
Ultrasonics | 2 | 2010 | 208 | 0.400 |
Why?
|
Physicians | 3 | 2021 | 4591 | 0.400 |
Why?
|
Fibrinolytic Agents | 3 | 2008 | 2084 | 0.390 |
Why?
|
Parotid Diseases | 2 | 2010 | 49 | 0.390 |
Why?
|
Skin Transplantation | 5 | 2018 | 1083 | 0.380 |
Why?
|
Skull Base | 1 | 2014 | 292 | 0.380 |
Why?
|
Ticlopidine | 2 | 2007 | 730 | 0.380 |
Why?
|
Submandibular Gland Neoplasms | 1 | 2011 | 10 | 0.380 |
Why?
|
Tongue | 3 | 2023 | 403 | 0.380 |
Why?
|
Clavicle | 6 | 2018 | 224 | 0.380 |
Why?
|
Vascular Surgical Procedures | 4 | 2020 | 1489 | 0.370 |
Why?
|
Foreign-Body Migration | 1 | 2013 | 219 | 0.370 |
Why?
|
Sarcoma, Myeloid | 1 | 2011 | 51 | 0.360 |
Why?
|
Otorhinolaryngologic Neoplasms | 1 | 2010 | 26 | 0.360 |
Why?
|
Nose Neoplasms | 3 | 2021 | 249 | 0.350 |
Why?
|
Prosthesis-Related Infections | 1 | 2015 | 488 | 0.350 |
Why?
|
Hypoglossal Nerve Diseases | 1 | 2010 | 8 | 0.350 |
Why?
|
Lymphatic Abnormalities | 1 | 2012 | 134 | 0.350 |
Why?
|
Skull Base Neoplasms | 4 | 2008 | 270 | 0.340 |
Why?
|
Preoperative Care | 3 | 2017 | 2242 | 0.340 |
Why?
|
Patient Care | 2 | 2020 | 622 | 0.340 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2010 | 30 | 0.340 |
Why?
|
Laser Therapy | 1 | 2017 | 1092 | 0.340 |
Why?
|
Fluoroscopy | 1 | 2014 | 947 | 0.330 |
Why?
|
Neoplasm Invasiveness | 8 | 2023 | 3595 | 0.330 |
Why?
|
Bone Neoplasms | 4 | 2017 | 2529 | 0.330 |
Why?
|
Dilatation | 2 | 2023 | 306 | 0.330 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 612 | 0.330 |
Why?
|
Digestive System Surgical Procedures | 1 | 2014 | 572 | 0.320 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 156 | 0.320 |
Why?
|
Risk Assessment | 13 | 2022 | 23995 | 0.320 |
Why?
|
Lipoma | 3 | 2002 | 293 | 0.310 |
Why?
|
Patients | 1 | 2015 | 907 | 0.310 |
Why?
|
Stomach | 1 | 2013 | 696 | 0.310 |
Why?
|
Follow-Up Studies | 20 | 2018 | 39106 | 0.310 |
Why?
|
Length of Stay | 6 | 2021 | 6425 | 0.300 |
Why?
|
Postoperative Period | 4 | 2018 | 1813 | 0.300 |
Why?
|
Hamartoma | 1 | 2010 | 235 | 0.300 |
Why?
|
Perioperative Care | 1 | 2016 | 1033 | 0.300 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 172 | 0.290 |
Why?
|
Face | 3 | 2011 | 1026 | 0.290 |
Why?
|
Tissue Transplantation | 2 | 2006 | 128 | 0.290 |
Why?
|
Combined Modality Therapy | 10 | 2021 | 8529 | 0.290 |
Why?
|
Hirudins | 1 | 2008 | 179 | 0.290 |
Why?
|
Survival Rate | 11 | 2021 | 12725 | 0.280 |
Why?
|
Counseling | 1 | 2015 | 1547 | 0.280 |
Why?
|
Intraoperative Period | 1 | 2008 | 510 | 0.280 |
Why?
|
Adult | 48 | 2024 | 221177 | 0.270 |
Why?
|
Ear Cartilage | 1 | 2006 | 62 | 0.270 |
Why?
|
Inpatients | 1 | 2018 | 2548 | 0.270 |
Why?
|
Intubation, Intratracheal | 2 | 2018 | 1329 | 0.270 |
Why?
|
Aged, 80 and over | 25 | 2021 | 58976 | 0.270 |
Why?
|
Vascular Malformations | 1 | 2012 | 468 | 0.270 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1007 | 0.260 |
Why?
|
Radiotherapy | 4 | 2021 | 1499 | 0.260 |
Why?
|
Clinical Competence | 4 | 2019 | 4792 | 0.260 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2006 | 97 | 0.250 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.250 |
Why?
|
Microcirculation | 3 | 2008 | 1273 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.250 |
Why?
|
Hematocrit | 2 | 2018 | 623 | 0.250 |
Why?
|
Random Allocation | 5 | 2010 | 2395 | 0.250 |
Why?
|
Ear Canal | 3 | 2007 | 147 | 0.250 |
Why?
|
Diagnosis, Differential | 11 | 2013 | 12974 | 0.240 |
Why?
|
Carotid Arteries | 1 | 2009 | 941 | 0.240 |
Why?
|
Mouth Rehabilitation | 1 | 2004 | 10 | 0.240 |
Why?
|
Tomography, X-Ray Computed | 14 | 2020 | 20570 | 0.240 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2007 | 344 | 0.240 |
Why?
|
Salivary Ducts | 1 | 2004 | 25 | 0.240 |
Why?
|
Physicians, Family | 1 | 2006 | 350 | 0.230 |
Why?
|
Nasal Cavity | 4 | 2021 | 304 | 0.230 |
Why?
|
Wound Healing | 5 | 2020 | 2805 | 0.230 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2007 | 2751 | 0.230 |
Why?
|
Deglutition | 3 | 2021 | 208 | 0.230 |
Why?
|
Skin Neoplasms | 5 | 2023 | 5821 | 0.230 |
Why?
|
RNA-Binding Protein FUS | 1 | 2024 | 76 | 0.230 |
Why?
|
Skull | 1 | 2008 | 818 | 0.220 |
Why?
|
Femoral Artery | 2 | 2005 | 826 | 0.220 |
Why?
|
Prognosis | 14 | 2021 | 29625 | 0.220 |
Why?
|
Bacteria | 1 | 2014 | 2199 | 0.220 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2015 | 4016 | 0.220 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3889 | 0.220 |
Why?
|
Osteosarcoma | 2 | 2000 | 897 | 0.220 |
Why?
|
Radiation Injuries | 2 | 2009 | 1189 | 0.210 |
Why?
|
Peripheral Nerves | 1 | 2006 | 479 | 0.210 |
Why?
|
Fibula | 3 | 2024 | 266 | 0.210 |
Why?
|
Neoplasms, Second Primary | 1 | 2011 | 1052 | 0.210 |
Why?
|
Rats, Sprague-Dawley | 6 | 2010 | 8181 | 0.210 |
Why?
|
Adenoma | 2 | 2011 | 2160 | 0.210 |
Why?
|
Veins | 1 | 2007 | 768 | 0.210 |
Why?
|
Neurilemmoma | 1 | 2008 | 526 | 0.210 |
Why?
|
Quality of Life | 8 | 2023 | 13367 | 0.200 |
Why?
|
External Fixators | 1 | 2002 | 99 | 0.200 |
Why?
|
Platelet Aggregation | 1 | 2005 | 771 | 0.200 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 196 | 0.200 |
Why?
|
Rhabdoid Tumor | 1 | 2024 | 210 | 0.200 |
Why?
|
Larynx | 2 | 2018 | 492 | 0.190 |
Why?
|
Salivary Glands, Minor | 1 | 2021 | 25 | 0.190 |
Why?
|
Immunohistochemistry | 8 | 2021 | 11076 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 16 | 2020 | 36426 | 0.190 |
Why?
|
Survival Analysis | 1 | 2014 | 10090 | 0.190 |
Why?
|
Cohort Studies | 10 | 2024 | 41487 | 0.180 |
Why?
|
Ear Neoplasms | 2 | 2014 | 118 | 0.180 |
Why?
|
Papillomaviridae | 3 | 2022 | 1119 | 0.180 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2021 | 61 | 0.180 |
Why?
|
Orbital Diseases | 1 | 2002 | 178 | 0.180 |
Why?
|
Embolization, Therapeutic | 2 | 2009 | 1418 | 0.180 |
Why?
|
Nasal Obstruction | 1 | 2002 | 160 | 0.180 |
Why?
|
Scapula | 2 | 2018 | 173 | 0.180 |
Why?
|
Forecasting | 3 | 2020 | 2928 | 0.180 |
Why?
|
Enoxaparin | 1 | 2003 | 391 | 0.180 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 1405 | 0.180 |
Why?
|
Speech Therapy | 1 | 2000 | 57 | 0.170 |
Why?
|
Hoarseness | 1 | 2020 | 62 | 0.170 |
Why?
|
Osteogenesis, Distraction | 2 | 2004 | 227 | 0.170 |
Why?
|
Speech Disorders | 1 | 2021 | 180 | 0.170 |
Why?
|
Pharyngeal Muscles | 1 | 2000 | 81 | 0.170 |
Why?
|
Spasm | 1 | 2000 | 130 | 0.170 |
Why?
|
Arteries | 2 | 2015 | 1123 | 0.170 |
Why?
|
Sialometaplasia, Necrotizing | 1 | 2019 | 6 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2021 | 225 | 0.160 |
Why?
|
Pilot Projects | 8 | 2023 | 8631 | 0.160 |
Why?
|
Cocaine-Related Disorders | 1 | 2002 | 461 | 0.160 |
Why?
|
Bone Transplantation | 1 | 2004 | 929 | 0.160 |
Why?
|
Rats | 7 | 2010 | 23742 | 0.160 |
Why?
|
Caregivers | 2 | 2004 | 2237 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 218 | 0.160 |
Why?
|
Neoplasm, Residual | 1 | 2024 | 1008 | 0.160 |
Why?
|
Jejunum | 2 | 2015 | 472 | 0.160 |
Why?
|
Shoulder | 2 | 2018 | 300 | 0.160 |
Why?
|
Surgical Instruments | 3 | 2010 | 383 | 0.160 |
Why?
|
Gene Fusion | 1 | 2021 | 356 | 0.150 |
Why?
|
Hospitalization | 1 | 2018 | 10723 | 0.150 |
Why?
|
Nose Deformities, Acquired | 1 | 2018 | 44 | 0.150 |
Why?
|
Esthetics | 2 | 2014 | 330 | 0.150 |
Why?
|
Gene Rearrangement | 2 | 2021 | 1125 | 0.150 |
Why?
|
Foreign Bodies | 1 | 2002 | 402 | 0.150 |
Why?
|
South Dakota | 2 | 2014 | 32 | 0.150 |
Why?
|
Nasal Mucosa | 1 | 2021 | 416 | 0.150 |
Why?
|
Disease-Free Survival | 5 | 2024 | 6814 | 0.150 |
Why?
|
Incidence | 6 | 2015 | 21353 | 0.150 |
Why?
|
Heparin | 1 | 2005 | 1634 | 0.150 |
Why?
|
Humidity | 2 | 2020 | 205 | 0.150 |
Why?
|
Air Pollutants, Occupational | 1 | 2020 | 407 | 0.150 |
Why?
|
Tracheostomy | 3 | 2014 | 426 | 0.150 |
Why?
|
Sound | 1 | 1999 | 257 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
Analysis of Variance | 3 | 2010 | 6228 | 0.140 |
Why?
|
Lymph Nodes | 3 | 2017 | 3466 | 0.140 |
Why?
|
Lymphoproliferative Disorders | 2 | 2003 | 531 | 0.140 |
Why?
|
Models, Biological | 1 | 2013 | 9469 | 0.140 |
Why?
|
Durapatite | 1 | 2018 | 163 | 0.140 |
Why?
|
Anastomotic Leak | 1 | 2018 | 163 | 0.140 |
Why?
|
Accessory Nerve | 1 | 1996 | 11 | 0.140 |
Why?
|
Biopsy, Fine-Needle | 3 | 2024 | 1118 | 0.140 |
Why?
|
Critical Pathways | 1 | 2020 | 474 | 0.130 |
Why?
|
Skull Neoplasms | 2 | 2007 | 173 | 0.130 |
Why?
|
Hypertrophy | 1 | 2018 | 561 | 0.130 |
Why?
|
Models, Animal | 3 | 2010 | 2112 | 0.130 |
Why?
|
Granulation Tissue | 1 | 2015 | 92 | 0.130 |
Why?
|
Connective Tissue | 1 | 2018 | 419 | 0.130 |
Why?
|
Algorithms | 5 | 2021 | 14031 | 0.130 |
Why?
|
Prosthesis Fitting | 1 | 2015 | 75 | 0.130 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1096 | 0.130 |
Why?
|
Massachusetts | 4 | 2017 | 8830 | 0.130 |
Why?
|
United States | 9 | 2020 | 72334 | 0.120 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 582 | 0.120 |
Why?
|
Meningioma | 1 | 2024 | 1218 | 0.120 |
Why?
|
Povidone-Iodine | 1 | 2015 | 55 | 0.120 |
Why?
|
Diverticulum | 1 | 1996 | 137 | 0.120 |
Why?
|
Necrosis | 2 | 2015 | 1611 | 0.120 |
Why?
|
Retreatment | 1 | 2017 | 598 | 0.120 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 802 | 0.120 |
Why?
|
Injections | 1 | 2018 | 830 | 0.120 |
Why?
|
Meningeal Neoplasms | 1 | 2024 | 1248 | 0.120 |
Why?
|
Actinomycosis | 1 | 2014 | 19 | 0.120 |
Why?
|
Attitude to Health | 1 | 2004 | 2025 | 0.120 |
Why?
|
Reoperation | 6 | 2018 | 4303 | 0.120 |
Why?
|
Clostridium Infections | 1 | 2021 | 558 | 0.120 |
Why?
|
Bacteremia | 1 | 2021 | 979 | 0.120 |
Why?
|
Hyaluronic Acid | 1 | 2018 | 483 | 0.120 |
Why?
|
Mastoid | 1 | 2014 | 100 | 0.110 |
Why?
|
Tumor Burden | 1 | 2020 | 1893 | 0.110 |
Why?
|
Lymphoma | 1 | 2003 | 1901 | 0.110 |
Why?
|
Radiography | 3 | 2010 | 6965 | 0.110 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 292 | 0.110 |
Why?
|
Chromates | 1 | 2013 | 22 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 926 | 0.110 |
Why?
|
Laryngeal Nerves | 1 | 1994 | 57 | 0.110 |
Why?
|
Caustics | 1 | 2013 | 32 | 0.110 |
Why?
|
Aspirin | 1 | 2005 | 3133 | 0.110 |
Why?
|
Hospitals, Teaching | 1 | 2018 | 1156 | 0.110 |
Why?
|
Single-Cell Analysis | 2 | 2022 | 2449 | 0.110 |
Why?
|
Sarcoma, Clear Cell | 1 | 2013 | 72 | 0.110 |
Why?
|
Drinking | 1 | 2014 | 198 | 0.110 |
Why?
|
Triage | 1 | 2020 | 986 | 0.110 |
Why?
|
Intraoperative Care | 1 | 2017 | 767 | 0.110 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2014 | 189 | 0.110 |
Why?
|
Anti-Infective Agents, Local | 1 | 2015 | 247 | 0.100 |
Why?
|
Family | 1 | 2004 | 3194 | 0.100 |
Why?
|
Infection Control | 1 | 2020 | 981 | 0.100 |
Why?
|
Alaska | 1 | 2012 | 69 | 0.100 |
Why?
|
Burns, Chemical | 1 | 2013 | 123 | 0.100 |
Why?
|
Injections, Subcutaneous | 2 | 2005 | 681 | 0.100 |
Why?
|
Emergency Medical Services | 2 | 2013 | 1923 | 0.100 |
Why?
|
Disease Models, Animal | 2 | 2010 | 18252 | 0.100 |
Why?
|
Carcinoma, Ductal | 1 | 2012 | 97 | 0.100 |
Why?
|
Risk Factors | 12 | 2020 | 74206 | 0.100 |
Why?
|
Hot Temperature | 2 | 2020 | 1440 | 0.100 |
Why?
|
Chi-Square Distribution | 2 | 2009 | 3416 | 0.100 |
Why?
|
Accidents, Occupational | 1 | 2013 | 249 | 0.100 |
Why?
|
Neuroma, Acoustic | 1 | 2015 | 459 | 0.100 |
Why?
|
Tacrolimus | 1 | 1995 | 733 | 0.100 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4915 | 0.100 |
Why?
|
Leg Injuries | 1 | 2013 | 179 | 0.100 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1992 | 64 | 0.100 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2011 | 15 | 0.090 |
Why?
|
Salivary Gland Diseases | 1 | 2011 | 37 | 0.090 |
Why?
|
Biopsy | 3 | 2022 | 6766 | 0.090 |
Why?
|
Adolescent | 13 | 2018 | 88319 | 0.090 |
Why?
|
Osteoradionecrosis | 1 | 2011 | 51 | 0.090 |
Why?
|
Paranasal Sinus Diseases | 1 | 2012 | 121 | 0.090 |
Why?
|
Ligation | 1 | 2012 | 448 | 0.090 |
Why?
|
Graft Rejection | 2 | 2014 | 4445 | 0.090 |
Why?
|
Femoral Neoplasms | 1 | 2011 | 84 | 0.090 |
Why?
|
Ukraine | 1 | 2011 | 149 | 0.090 |
Why?
|
Oropharynx | 1 | 2011 | 138 | 0.090 |
Why?
|
Educational Measurement | 1 | 2017 | 1254 | 0.090 |
Why?
|
Fistula | 1 | 2012 | 212 | 0.090 |
Why?
|
Steel | 1 | 2010 | 27 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1739 | 0.090 |
Why?
|
Chyle | 1 | 2010 | 19 | 0.090 |
Why?
|
Internship and Residency | 3 | 2019 | 5880 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8654 | 0.090 |
Why?
|
Muscular Diseases | 2 | 2000 | 553 | 0.090 |
Why?
|
Young Adult | 9 | 2021 | 59243 | 0.090 |
Why?
|
Frozen Sections | 1 | 2010 | 153 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2143 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1685 | 0.080 |
Why?
|
Occupational Exposure | 1 | 2020 | 1813 | 0.080 |
Why?
|
Anticoagulants | 1 | 2005 | 4812 | 0.080 |
Why?
|
Cranial Nerves | 1 | 2010 | 98 | 0.080 |
Why?
|
Hemostasis, Surgical | 1 | 2010 | 126 | 0.080 |
Why?
|
Cochlea | 1 | 2015 | 845 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2521 | 0.080 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 242 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.080 |
Why?
|
Surgery, Plastic | 1 | 1996 | 643 | 0.080 |
Why?
|
Optic Disk Drusen | 1 | 2009 | 38 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2014 | 1682 | 0.080 |
Why?
|
Survivors | 1 | 2019 | 2371 | 0.080 |
Why?
|
Poverty | 2 | 2020 | 2698 | 0.080 |
Why?
|
Hematoma | 2 | 2005 | 768 | 0.070 |
Why?
|
Quality of Health Care | 2 | 2016 | 4330 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2759 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2000 | 4948 | 0.070 |
Why?
|
Monitoring, Physiologic | 2 | 2013 | 1779 | 0.070 |
Why?
|
Range of Motion, Articular | 1 | 2014 | 1588 | 0.070 |
Why?
|
Occlusive Dressings | 1 | 2007 | 52 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2827 | 0.070 |
Why?
|
Speech | 2 | 2021 | 554 | 0.070 |
Why?
|
Health Care Surveys | 2 | 2016 | 2426 | 0.070 |
Why?
|
Stents | 1 | 2018 | 3179 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7581 | 0.070 |
Why?
|
Splints | 1 | 2007 | 108 | 0.070 |
Why?
|
Thigh | 2 | 1999 | 241 | 0.070 |
Why?
|
Probability | 2 | 2009 | 2477 | 0.070 |
Why?
|
Animals | 10 | 2015 | 168459 | 0.070 |
Why?
|
Health Status Indicators | 2 | 2004 | 970 | 0.070 |
Why?
|
Cystadenocarcinoma | 1 | 2005 | 54 | 0.070 |
Why?
|
Sphenoid Sinus | 2 | 2006 | 99 | 0.060 |
Why?
|
Trismus | 1 | 2005 | 33 | 0.060 |
Why?
|
Manipulation, Orthopedic | 1 | 2005 | 40 | 0.060 |
Why?
|
Accidental Falls | 1 | 2013 | 1068 | 0.060 |
Why?
|
Nose | 2 | 2019 | 521 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2373 | 0.060 |
Why?
|
Child | 11 | 2010 | 80153 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12059 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3242 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2024 | 1606 | 0.060 |
Why?
|
Carcinoma, Basal Cell | 2 | 2007 | 560 | 0.060 |
Why?
|
Tomography, Optical Coherence | 2 | 2009 | 2917 | 0.060 |
Why?
|
Tissue Survival | 1 | 2004 | 119 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3808 | 0.060 |
Why?
|
Mesenchymoma | 1 | 2024 | 49 | 0.060 |
Why?
|
Angiography | 1 | 2010 | 1595 | 0.060 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2008 | 328 | 0.060 |
Why?
|
Carcinoma, Large Cell | 1 | 2004 | 113 | 0.060 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2006 | 251 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7827 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.060 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 736 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2010 | 6485 | 0.060 |
Why?
|
Nursing Assessment | 1 | 2004 | 106 | 0.060 |
Why?
|
Liver Transplantation | 1 | 1995 | 2330 | 0.060 |
Why?
|
Recombinant Proteins | 2 | 2015 | 6534 | 0.050 |
Why?
|
Prospective Studies | 8 | 2021 | 54425 | 0.050 |
Why?
|
Intergenerational Relations | 1 | 2004 | 67 | 0.050 |
Why?
|
Reed-Sternberg Cells | 1 | 2003 | 72 | 0.050 |
Why?
|
Developing Countries | 1 | 2016 | 2885 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3270 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 698 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6484 | 0.050 |
Why?
|
Neuromuscular Agents | 1 | 2004 | 147 | 0.050 |
Why?
|
Rabbits | 2 | 2006 | 4772 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.050 |
Why?
|
Vascular Patency | 1 | 2005 | 911 | 0.050 |
Why?
|
Health Personnel | 1 | 2016 | 3335 | 0.050 |
Why?
|
Hypophysectomy | 1 | 2001 | 114 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2022 | 14666 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2006 | 12341 | 0.050 |
Why?
|
Sensation | 1 | 2023 | 337 | 0.050 |
Why?
|
Anesthesia, General | 1 | 2009 | 1174 | 0.050 |
Why?
|
Mucocele | 1 | 2001 | 51 | 0.050 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2005 | 517 | 0.050 |
Why?
|
Submandibular Gland | 1 | 2001 | 87 | 0.050 |
Why?
|
Self-Assessment | 1 | 2004 | 396 | 0.050 |
Why?
|
Transplantation, Autologous | 1 | 2006 | 2115 | 0.050 |
Why?
|
Salivary Glands | 1 | 2022 | 229 | 0.050 |
Why?
|
Esophagoscopes | 1 | 2001 | 16 | 0.050 |
Why?
|
Transplantation, Heterotopic | 1 | 2001 | 174 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2024 | 532 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 39967 | 0.050 |
Why?
|
Gastric Mucosa | 1 | 2004 | 604 | 0.050 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2024 | 455 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3092 | 0.050 |
Why?
|
Prevalence | 2 | 2016 | 15732 | 0.050 |
Why?
|
Botulinum Toxins, Type A | 1 | 2004 | 237 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2012 | 1852 | 0.040 |
Why?
|
Incisor | 1 | 2001 | 174 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2021 | 314 | 0.040 |
Why?
|
Bone Marrow | 1 | 2010 | 2911 | 0.040 |
Why?
|
Radius | 1 | 2023 | 441 | 0.040 |
Why?
|
Skin | 1 | 1994 | 4484 | 0.040 |
Why?
|
Adenoidectomy | 1 | 2001 | 167 | 0.040 |
Why?
|
Ilium | 1 | 2000 | 155 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2011 | 5247 | 0.040 |
Why?
|
Granuloma, Foreign-Body | 1 | 2000 | 42 | 0.040 |
Why?
|
Psychoacoustics | 1 | 1999 | 55 | 0.040 |
Why?
|
Osteochondroma | 1 | 1999 | 44 | 0.040 |
Why?
|
Hypopharynx | 1 | 2019 | 53 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 100 | 0.040 |
Why?
|
Dermis | 1 | 2000 | 202 | 0.040 |
Why?
|
Contrast Media | 1 | 2012 | 5311 | 0.040 |
Why?
|
Esophagectomy | 1 | 2003 | 468 | 0.040 |
Why?
|
Cytodiagnosis | 1 | 2022 | 447 | 0.040 |
Why?
|
Hemangiopericytoma | 1 | 1999 | 71 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5428 | 0.040 |
Why?
|
Macular Degeneration | 1 | 2006 | 1007 | 0.040 |
Why?
|
Surgical Wound Dehiscence | 1 | 2000 | 213 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2020 | 3514 | 0.040 |
Why?
|
Neck Injuries | 1 | 2000 | 160 | 0.040 |
Why?
|
Catheter-Related Infections | 1 | 2021 | 273 | 0.040 |
Why?
|
Sclerosing Solutions | 1 | 1998 | 79 | 0.040 |
Why?
|
Professional Autonomy | 1 | 2019 | 171 | 0.040 |
Why?
|
Palate | 1 | 2018 | 124 | 0.040 |
Why?
|
Speech Intelligibility | 1 | 1998 | 79 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4174 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2002 | 607 | 0.040 |
Why?
|
Burkitt Lymphoma | 1 | 2000 | 335 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 26125 | 0.040 |
Why?
|
Speech Acoustics | 1 | 1998 | 154 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 9053 | 0.040 |
Why?
|
Age Factors | 1 | 2014 | 18395 | 0.040 |
Why?
|
Elasticity | 1 | 1999 | 655 | 0.040 |
Why?
|
Sclerotherapy | 1 | 1998 | 182 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2000 | 544 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1222 | 0.030 |
Why?
|
Doxycycline | 1 | 1998 | 344 | 0.030 |
Why?
|
Clindamycin | 1 | 2016 | 139 | 0.030 |
Why?
|
Pressure | 1 | 1999 | 1154 | 0.030 |
Why?
|
Arnold-Chiari Malformation | 1 | 1997 | 158 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2003 | 1374 | 0.030 |
Why?
|
Patient Selection | 2 | 2000 | 4244 | 0.030 |
Why?
|
Specialization | 1 | 2020 | 778 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2003 | 1378 | 0.030 |
Why?
|
Equipment Design | 2 | 2001 | 3510 | 0.030 |
Why?
|
Craniocerebral Trauma | 1 | 2000 | 490 | 0.030 |
Why?
|
Retina | 1 | 2006 | 2659 | 0.030 |
Why?
|
Pakistan | 1 | 2016 | 292 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1358 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 1 | 2015 | 210 | 0.030 |
Why?
|
DNA, Viral | 1 | 2022 | 2202 | 0.030 |
Why?
|
Speech Production Measurement | 1 | 1994 | 96 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1626 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2020 | 0.030 |
Why?
|
Immunoglobulin Light Chains | 1 | 1995 | 285 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1092 | 0.030 |
Why?
|
Vocal Cord Paralysis | 1 | 1997 | 272 | 0.030 |
Why?
|
Hepatocyte Growth Factor | 1 | 2015 | 270 | 0.030 |
Why?
|
Activating Transcription Factor 1 | 1 | 2013 | 26 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6374 | 0.030 |
Why?
|
Electroplating | 1 | 2013 | 7 | 0.030 |
Why?
|
Neurosurgery | 1 | 2020 | 679 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2024 | 2803 | 0.030 |
Why?
|
Neutralization Tests | 1 | 2015 | 728 | 0.030 |
Why?
|
Bangladesh | 1 | 2016 | 736 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 22176 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 589 | 0.030 |
Why?
|
Neurites | 1 | 2015 | 391 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2015 | 592 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 846 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3272 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6225 | 0.030 |
Why?
|
Carcinoma, Papillary | 1 | 1998 | 785 | 0.030 |
Why?
|
S100 Proteins | 1 | 2013 | 218 | 0.030 |
Why?
|
Hair Cells, Auditory | 1 | 2015 | 381 | 0.030 |
Why?
|
Burn Units | 1 | 2013 | 143 | 0.030 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2013 | 233 | 0.030 |
Why?
|
Neuroectodermal Tumors | 1 | 2012 | 22 | 0.030 |
Why?
|
Child, Preschool | 3 | 2005 | 42230 | 0.030 |
Why?
|
RNA-Binding Protein EWS | 1 | 2013 | 210 | 0.020 |
Why?
|
Touch | 1 | 1994 | 313 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1648 | 0.020 |
Why?
|
Health Services | 1 | 2016 | 752 | 0.020 |
Why?
|
Health Status | 1 | 2004 | 4077 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15266 | 0.020 |
Why?
|
Etoposide | 1 | 2012 | 634 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2021 | 2986 | 0.020 |
Why?
|
Cough | 1 | 1994 | 594 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2015 | 781 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9420 | 0.020 |
Why?
|
Paranasal Sinuses | 1 | 2012 | 265 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 11742 | 0.020 |
Why?
|
Mental Health | 1 | 2004 | 3250 | 0.020 |
Why?
|
India | 1 | 2016 | 2348 | 0.020 |
Why?
|
Radiotherapy Dosage | 2 | 2006 | 2898 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2006 | 7390 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2000 | 2775 | 0.020 |
Why?
|
Infant | 3 | 2002 | 36192 | 0.020 |
Why?
|
Sarcoma | 2 | 2012 | 1801 | 0.020 |
Why?
|
Focus Groups | 1 | 2014 | 1413 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3639 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 899 | 0.020 |
Why?
|
Survival | 1 | 2008 | 161 | 0.020 |
Why?
|
Gene Amplification | 1 | 2012 | 1089 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3443 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1403 | 0.020 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2008 | 58 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2013 | 809 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2510 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1408 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5492 | 0.020 |
Why?
|
Reaction Time | 1 | 1994 | 2082 | 0.020 |
Why?
|
Ear, External | 1 | 2007 | 165 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2009 | 411 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4580 | 0.020 |
Why?
|
Neutrons | 1 | 2006 | 77 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3905 | 0.020 |
Why?
|
Eye Enucleation | 1 | 2006 | 128 | 0.020 |
Why?
|
Cranial Fossa, Posterior | 1 | 2006 | 135 | 0.020 |
Why?
|
Amifostine | 1 | 2005 | 40 | 0.020 |
Why?
|
Anesthetics, Intravenous | 1 | 2009 | 395 | 0.020 |
Why?
|
Cisplatin | 1 | 2012 | 1651 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2006 | 123 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7967 | 0.020 |
Why?
|
Ear, Middle | 1 | 2007 | 339 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 1998 | 2332 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2169 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2220 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12463 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3492 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2013 | 1897 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3877 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2009 | 1147 | 0.010 |
Why?
|
Registries | 1 | 2020 | 8224 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2009 | 1235 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4352 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9486 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3801 | 0.010 |
Why?
|
Orbital Neoplasms | 1 | 2006 | 222 | 0.010 |
Why?
|
Adenocarcinoma | 3 | 2008 | 6346 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 2865 | 0.010 |
Why?
|
Carbon | 1 | 2006 | 666 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2005 | 883 | 0.010 |
Why?
|
Propofol | 1 | 2009 | 603 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2012 | 2057 | 0.010 |
Why?
|
Visual Fields | 1 | 2009 | 1062 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2557 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18965 | 0.010 |
Why?
|
Vision Disorders | 1 | 2009 | 1088 | 0.010 |
Why?
|
Protons | 1 | 2006 | 1116 | 0.010 |
Why?
|
Groin | 1 | 2001 | 106 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2021 | 21012 | 0.010 |
Why?
|
Eustachian Tube | 1 | 2001 | 99 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12990 | 0.010 |
Why?
|
Paclitaxel | 1 | 2005 | 1732 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7407 | 0.010 |
Why?
|
Bone Plates | 1 | 1999 | 466 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5671 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23445 | 0.010 |
Why?
|
Bone Screws | 1 | 1999 | 532 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4063 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15842 | 0.010 |
Why?
|
Osteotomy | 1 | 1999 | 837 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1998 | 1834 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 9000 | 0.010 |
Why?
|
HIV Infections | 1 | 1998 | 17351 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13639 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2001 | 2491 | 0.000 |
Why?
|
Mice | 1 | 2015 | 81525 | 0.000 |
Why?
|
Tissue Donors | 1 | 1998 | 2331 | 0.000 |
Why?
|
Mutation | 1 | 2012 | 30052 | 0.000 |
Why?
|
Brain | 1 | 2009 | 27112 | 0.000 |
Why?
|